Literature DB >> 6301709

Immunoassay of three enolase isozymes in human serum and in blood cells.

K Kato, R Asai, A Shimizu, F Suzuki, Y Ariyoshi.   

Abstract

Sandwich enzyme immunoassay procedures for measurement of three human enolase isozymes (alpha alpha, alpha gamma and gamma gamma forms) were developed by use of purified antibodies specific to the alpha or the gamma subunit of enolase. The assay systems consisted of polystyrene balls with immobilized antibody F(ab')2 fragments and antibody Fab' fragments labeled with beta-D-galactosidase from E. coli. The measurable range was from 3 pg to 10 ng of each enolase isozyme per assay tube, and the levels of the three enolases in human sera and isolated blood cells were determined. Serum samples from healthy adults contained about 60, 8, and 2 ng/ml of alpha alpha, alpha gamma, and gamma gamma enolases, respectively. Red blood cells and platelets had about 4, 1, and 0.1 ng/10(6) cells of alpha alpha, alpha gamma, and gamma gamma enolases, respectively. Lymphocytes (mononuclear cells) contained larger amounts of all three enolases (alpha alpha, 370 ng/10(6) cells; alpha gamma, 30 ng/10(6) cells; gamma gamma, 2.7 ng/10(6) cells). The levels of three enolase isozymes in sera of patients with small-cell cancer of the lung were also determined.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301709     DOI: 10.1016/0009-8981(83)90162-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  20 in total

Review 1.  Cerebrospinal fluid markers in neurological disorders.

Authors:  A R Massaro; G Scivoletto; P Tonali
Journal:  Ital J Neurol Sci       Date:  1990-12

2.  Enolase isozymes in renal tubules and renal cell carcinoma.

Authors:  H Haimoto; M Takashi; T Koshikawa; J Asai; K Kato
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

3.  Immunohistochemical characterization of a set of monoclonal antibodies to human neuron-specific enolase.

Authors:  B Seshi; L True; D Carter; J Rosai
Journal:  Am J Pathol       Date:  1988-05       Impact factor: 4.307

4.  Enolase isozymes in seminoma.

Authors:  M Takashi; H Haimoto; T Nagai; T Koshikawa; K Kato
Journal:  Urol Res       Date:  1990

5.  Elevated levels of the alpha subunit of GTP-binding protein Go in cerebrospinal fluid of patients with neurological disorders.

Authors:  T Murayama; A Takahashi; T Asano; K Kato
Journal:  J Mol Neurosci       Date:  1989       Impact factor: 3.444

Review 6.  Advanced Coats' disease.

Authors:  B G Haik
Journal:  Trans Am Ophthalmol Soc       Date:  1991

7.  Admission plasma levels of the neuronal injury marker neuron-specific enolase are associated with mortality and delirium in sepsis.

Authors:  Jason D Christie; Nuala J Meyer; Brian J Anderson; John P Reilly; Michael G S Shashaty; Jessica A Palakshappa; Alex Wysoczanski; Thomas G Dunn; Altaf Kazi; Anna Tommasini; Mark E Mikkelsen; William D Schweickert; Dennis L Kolson
Journal:  J Crit Care       Date:  2016-06-23       Impact factor: 3.425

8.  Gamma-enolase activity in choroidal melanoma.

Authors:  C E Margo; M Lavellée
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

9.  Electrophoretic assessment of aqueous and serum neurone-specific enolase in retinoblastoma and ocular malignant melanoma.

Authors:  B S Shine; J Hungerford; B Vaghela; G A Sheraidah
Journal:  Br J Ophthalmol       Date:  1990-07       Impact factor: 4.638

10.  Concentrations of several proteins characteristic of nervous tissue in cerebral cortex of patients with Alzheimer's disease.

Authors:  K Kato; N Kurobe; F Suzuki; R Morishita; T Asano; T Sato; T Inagaki
Journal:  J Mol Neurosci       Date:  1991       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.